News Search Results
Jan 14, 2025, 17:40 ET Multiple Sclerosis Market in US to Grow by USD 4.99 Billion from 2025-2029, Driven by a Strong Vendor Pipeline and AI-Powered Market Evolution - Technavio
biomarkers, clinical data, and medical advancements to understand MS better and improve clinical outcomes. The use of immune system modulation drugs and biotechnology in MS treatment is a promising area of medical research. Public health initiatives aim to improve the quality of life of MS patients by addressing
More news about: Technavio
Jan 14, 2025, 17:31 ET Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight
clinical and non-clinical stage products, and the key HER2-mutant non-small cell lung cancer companies, including Dizal Pharmaceuticals, Puma Biotechnology, AstraZeneca, Jiangsu Hengrui Medicine, among others.
More news about: DelveInsight Business Research, LLP
Jan 14, 2025, 12:43 ET Next Generation Gene Therapeutics (NGGT) Announces Publication of Early Clinical Trial Results for NGGT001 for the Treatment of Bietti's Crystalline Dystrophy (BCD)
Jan. 14, 2025 /PRNewswire/ -- NGGT Inc., ("Next Generation Gene Therapeutics" or "NGGT" or the "Company"), a clinical-stage biotechnology company pioneering the next wave of gene therapy innovation for genetic rare diseases, today announced the publication in the journal
More news about: NGGT Inc.
Jan 14, 2025, 09:30 ET Keylicon Biosciences Secures Exclusive Rights to Modified Self-Amplifying RNA Technology
Nature Biotechnology publication, the research was led by Professors Mark Grinstaff and Wilson Wong,
More news about: Keylicon Biosciences
Jan 14, 2025, 09:07 ET BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell Therapy Facility Development
the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors. About Orchestra Life SciencesOrchestra Life Sciences (OLS) is a technical consultancy providing strategic support
More news about: BioCentriq, Inc.
Jan 14, 2025, 09:00 ET Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer
Scholarship Foundation. He completed his fellowship in Medical Oncology at MD Anderson Cancer Center. About Neomorph Neomorph is a biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against 'undruggable' targets.
More news about: Neomorph
Jan 14, 2025, 09:00 ET The Bloc Fuels Global Growth, Expands Medical Communications Capabilities and Operations in Asia Pacific, Middle East, and Africa
education. This expansion enables The Bloc to offer its world-class scientific and strategic services to a broader array of global pharmaceutical, biotechnology, and healthcare clients while tapping into the region's rich talent pool and dynamic healthcare landscape. This initiative is part of The
More news about: The Bloc
Jan 14, 2025, 09:00 ET FIZE Medical Secures $30 Million in Series A Funding to Drive Innovations in Fluid Management Technology Culminating in a $14 Million Series A-4 Round Led by Rapha Capital Management
LLC Rapha Capital Management, LLC is an investment advisory firm focused on making strategic investments in early stage, non-public biotechnology companies, through special purpose, joint venture entities (SPVs), which it manages. Rapha Capital was founded by its President, Kevin
More news about: FIZE Medical
Jan 14, 2025, 09:00 ET Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jan 14, 2025, 08:55 ET MedTherapy Announces Innovative Global Measures to Meet Acute Manufacturing Challenges for 'CAR-T' cell gene Therapies to Make them more Affordable and Accessible Worldwide
2025 /PRNewswire/ -- MedTherapy, a Boston based Chimeric Antigen Receptor (CAR) -T cell therapy biotechnology company, made its announcements at the JP Morgan Annual Healthcare Conference in San Francisco, CA, that it has
More news about: MedTherapy Biotechnology
Jan 14, 2025, 08:00 ET The Leukemia & Lymphoma Society Names Lore Gruenbaum, Ph.D., New Chief Scientific Officer
research but also make science more accessible to everyone." Under her leadership, TAP launched 12 new partnerships with U.S. and European biotechnology companies to accelerate high-risk, innovative blood cancer treatments. TAP partner companies also announced or started more than a dozen new clinical
More news about: The Leukemia & Lymphoma Society (LLS)
Jan 14, 2025, 08:00 ET BioVaxys Technology Corp. to Present at the Emerging Growth Conference on Thursday January 16, 2025
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Jan 14, 2025, 07:30 ET HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Jan 14, 2025, 07:00 ET Syantra, Inc. Welcomes STEM Advocate and Breast Cancer Conqueror Holly Smithson to Its Board of Directors
CALGARY, AB, Jan. 14, 2025 /PRNewswire/ - Syantra, Inc., a precision biotechnology company revolutionizing cancer detection and treatment, proudly announces the appointment of Holly Smithson to its
More news about: Syantra Inc.
Jan 14, 2025, 07:00 ET CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors
Company's Board of Directors effective on January 15, 2025. Dr. Glicklich has more than 20 years of experience in the biotechnology industry and currently serves as Chief Medical Officer of Nuvig Therapeutics.
More news about: CalciMedica, Inc.
Jan 14, 2025, 05:00 ET REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases
designations from the U.S. Food and Drug Administration (FDA). ABOUT REGENXBIO Inc.REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development
More news about: REGENXBIO Inc.
Jan 14, 2025, 02:03 ET GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability
the building blocks needed to develop groundbreaking treatments and products. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a trusted global leader, GenScript has a team of over 5,000 employees and has served more than 200,000 customers across 100 countries.
More news about: GenScript Biotech Corporation
Jan 13, 2025, 19:03 ET FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
LinkedIn. 5. About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients' lives and to create value for shareholders and our communities.
More news about: Eisai Inc.
Jan 13, 2025, 17:45 ET UK Cold Chain Logistics Market to Grow by USD 8.50 Billion from 2025-2029, Driven by RFID Adoption and AI-Redefined Market Landscape - Technavio
crucial role in e-commerce and food delivery services, ensuring the timely and safe delivery of healthcare products and fresh food. In the realm of biotechnology, cold chain logistics is essential for the transportation and storage of biological materials, such as cell lines and vaccines, used in drug development
More news about: Technavio
Jan 13, 2025, 12:00 ET BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
Slovenia and Sweden. "Intellectual property provides the foundation on which advances in the biotechnology industry are built, particularly for rare genetic conditions," said Alexander Hardy, president and chief executive
More news about: BioMarin Pharmaceutical Inc.
Jan 13, 2025, 11:15 ET Biohaven Highlights Portfolio Progress, Innovation, and Anticipated Milestones at the 43rd Annual J.P. Morgan Healthcare Conference; Reports Positive Degrader Data with Rapid, Deep, and Selective Lowering of Galactose-Deficient IgA1 with Next Generation Potential Therapy for IgA Nephropathy
expression. The first-in-human study is planned to commence in 1H 2025. Announced a multi-target collaboration with Merus, an oncology-focused biotechnology company developing innovative, multi-specific (Biclonics® and Triclonics®) antibodies, to co-develop three programs encompassing
More news about: Biohaven Ltd.
Jan 13, 2025, 11:00 ET Rise Therapeutics Receives FDA IND Clearance to Initiate Clinical Testing of R-5780 in Cancer
ROCKVILLE, Md., Jan. 13, 2025 /PRNewswire/ -- Rise Therapeutics, a biotechnology company engaged in developing novel oral Immunotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational
More news about: Rise Therapeutics
Jan 13, 2025, 11:00 ET Ex-Deep Genomics, Moderna Execs Get Backing Led by Gradient to Develop Next-Generation mRNA Therapeutics with AI
Moore. About Kerna Laboratories Inc.Kerna Laboratories Inc. is a San Francisco-based AI biotechnology company dedicated to unlocking the full potential of mRNA. Founded by leading experts, the company combines advanced AI and cutting-edge science
More news about: Kerna Laboratories, Inc
Jan 13, 2025, 10:30 ET Spatial Genomics & Transcriptomics Market to Hit USD 995.7 Million by 2029 with 12.4% CAGR | MarketsandMarkets™
transcriptomics services market into pharmaceutical & biotechnology corporations, academia & research institutes, and other end users including small scale-CROs & CDMOs, and clinical diagnostic laboratories. Following pharmaceutical and biotechnology firms, the academic and research industry accounted
More news about: MarketsandMarkets
Jan 13, 2025, 10:01 ET Robotic Welding Cell Market Size Worth $3.72 Bn, Globally, by 2031 Growing at 11.9% CAGR | Exclusive Report by The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners